Trastuzumab Completed Phase 2 Trials for Stage IV Breast Cancer / Male Breast Cancer / Her2-Positive Breast Cancer / Recurrent Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00004888Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer
NCT00006228Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer
NCT00024154Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer
NCT00077376Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer